tiprankstipranks
Icecure Medical Ltd. (ICCM)
NASDAQ:ICCM
US Market
ICCM
Icecure Medical
RESEARCH TOOLSreports
Want to see ICCM full AI Analyst Report?

Icecure Medical (ICCM) Stock Forecast & Price Target

337 Followers
See the Price Targets and Ratings of:

ICCM Analyst Ratings

Strong Buy
3Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Icecure
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ICCM Stock 12 Month Forecast

Average Price Target

$44.50
▲(5074.42% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Icecure Medical in the last 3 months. The average price target is $44.50 with a high forecast of $73.50 and a low forecast of $30.00. The average price target represents a 5074.42% change from the last price of $0.86.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","39":"$39","74":"$74","21.5":"$21.5","56.5":"$56.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":73.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$73.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$44.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$30.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,21.5,39,56.5,74],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.28,10.527692307692309,15.775384615384617,21.023076923076925,26.270769230769233,31.51846153846154,36.76615384615385,42.01384615384616,47.261538461538464,52.50923076923077,57.75692307692308,63.00461538461539,68.2523076923077,{"y":73.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.28,8.296923076923077,11.313846153846153,14.330769230769231,17.34769230769231,20.364615384615387,23.38153846153846,26.39846153846154,29.415384615384617,32.432307692307695,35.44923076923077,38.46615384615385,41.48307692307692,{"y":44.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.28,7.181538461538461,9.083076923076923,10.984615384615385,12.886153846153846,14.787692307692307,16.689230769230768,18.59076923076923,20.49230769230769,22.393846153846155,24.295384615384616,26.196923076923078,28.09846153846154,{"y":30,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":30.024,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.6,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.475,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.375,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.453,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.303,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.492,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.083,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.03,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.039,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.033,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.28,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$73.50Average Price Target$44.50Lowest Price Target$30.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Brookline Capital Markets Analyst forecast on ICCM
Kemp Dolliver
Brookline Capital Markets
Brookline Capital Markets
$73.5
Buy
8446.51%
Upside
Reiterated
06/17/26
IceCure Medical business 'moving in the right direction,' says BrooklineIceCure Medical business 'moving in the right direction,' says Brookline
Maxim Group Analyst forecast on ICCM
Anthony Vendetti
Maxim Group
Maxim Group
$90→$30
Buy
3388.37%
Upside
Reiterated
05/14/26
IceCure Medical price target lowered to $1 from $3 at MaximIceCure Medical price target lowered to $1 from $3 at Maxim
Alliance Global Partners Analyst forecast on ICCM
Scott Henry
Alliance Global Partners
Alliance Global Partners
$30
Buy
3388.37%
Upside
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Icecure Medical (NASDAQ: ICCM) and Upstream Bio, Inc. (NASDAQ: UPB)
H.C. Wainwright Analyst forecast on ICCM
Yi Chen
H.C. Wainwright
H.C. Wainwright
$60→$75
Buy
8620.93%
Upside
Reiterated
10/07/25
IceCure Medical price target raised to $2.50 from $2 at H.C. WainwrightIceCure Medical price target raised to $2.50 from $2 at H.C. Wainwright
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Brookline Capital Markets Analyst forecast on ICCM
Kemp Dolliver
Brookline Capital Markets
Brookline Capital Markets
$73.5
Buy
8446.51%
Upside
Reiterated
06/17/26
IceCure Medical business 'moving in the right direction,' says BrooklineIceCure Medical business 'moving in the right direction,' says Brookline
Maxim Group Analyst forecast on ICCM
Anthony Vendetti
Maxim Group
Maxim Group
$90→$30
Buy
3388.37%
Upside
Reiterated
05/14/26
IceCure Medical price target lowered to $1 from $3 at MaximIceCure Medical price target lowered to $1 from $3 at Maxim
Alliance Global Partners Analyst forecast on ICCM
Scott Henry
Alliance Global Partners
Alliance Global Partners
$30
Buy
3388.37%
Upside
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Icecure Medical (NASDAQ: ICCM) and Upstream Bio, Inc. (NASDAQ: UPB)
H.C. Wainwright Analyst forecast on ICCM
Yi Chen
H.C. Wainwright
H.C. Wainwright
$60→$75
Buy
8620.93%
Upside
Reiterated
10/07/25
IceCure Medical price target raised to $2.50 from $2 at H.C. WainwrightIceCure Medical price target raised to $2.50 from $2 at H.C. Wainwright
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Icecure Medical

3 Months
Anthony VendettiMaxim Group
Success Rate
7/26 ratings generated profit
27%
Average Return
-3.86%
Copying Anthony Vendetti's trades and holding each position for 3 Months would result in 26.92% of your transactions generating a profit, with an average return of -3.86% per trade.
1 Year
Yi ChenH.C. Wainwright
Success Rate
6/15 ratings generated profit
40%
Average Return
-18.67%
Copying Yi Chen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -18.67% per trade.
2 Years
Anthony VendettiMaxim Group
Success Rate
2/26 ratings generated profit
8%
Average Return
-49.73%
Copying Anthony Vendetti's trades and holding each position for 2 Years would result in 7.69% of your transactions generating a profit, with an average return of -49.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ICCM Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
4
3
5
4
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
5
4
4
In the current month, ICCM has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ICCM average Analyst price target in the past 3 months is 44.50.
Each month's total comprises the sum of three months' worth of ratings.

ICCM Financial Forecast

ICCM Earnings Forecast

Next quarter’s earnings estimate for ICCM is -$1.52 with a range of -$1.80 to -$0.95. The previous quarter’s EPS was -$1.80. ICCM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ICCM has Performed in-line its overall industry.
Next quarter’s earnings estimate for ICCM is -$1.52 with a range of -$1.80 to -$0.95. The previous quarter’s EPS was -$1.80. ICCM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ICCM has Performed in-line its overall industry.

ICCM Sales Forecast

Next quarter’s sales forecast for ICCM is $1.45M with a range of $709.00K to $2.53M. The previous quarter’s sales results were $911.00K. ICCM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ICCM has Performed in-line its overall industry.
Next quarter’s sales forecast for ICCM is $1.45M with a range of $709.00K to $2.53M. The previous quarter’s sales results were $911.00K. ICCM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ICCM has Performed in-line its overall industry.

ICCM Stock Forecast FAQ

What is ICCM’s average 12-month price target, according to analysts?
Based on analyst ratings, Icecure Medical Ltd.’s 12-month average price target is 44.50.
    What is ICCM’s upside potential, based on the analysts’ average price target?
    Icecure Medical Ltd. has 5074.42% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ICCM a Buy, Sell or Hold?
          Icecure Medical Ltd. has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Icecure Medical Ltd.’s price target?
            The average price target for Icecure Medical Ltd. is 44.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $73.50 ,the lowest forecast is $30.00. The average price target represents 5074.42% Increase from the current price of $0.86.
              What do analysts say about Icecure Medical Ltd.?
              Icecure Medical Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of ICCM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.